Search results for "kidney cancer"

showing 10 items of 33 documents

External validation of the preoperative Karakiewicz nomogram in a large multicentre series of patients with renal cell carcinoma

2012

Purpose: To perform a formal external validation of the preoperative Karakiewicz nomogram (KN) for the prediction of cancer-specific survival (CSS) using a large series of surgically treated patients diagnosed with organ-confined or metastatic renal cell carcinoma (RCC). Methods: Patient population originated from a series of retrospectively gathered cases that underwent radical or partial nephrectomy between years 1995 and 2007 for suspicion of kidney cancer. The original Cox coefficients were used to generate the predicted risk of CSS at 1, 2, 5, and 10 years following surgery and compared to the observed risk of CSS in the current population. External validation was quantified using meas…

Malemedicine.medical_treatmentKarakiewicz NomogramPredictive Value of TestNephrectomyNomogramPreoperative nomogram; Renal cell carcinoma; Prognostic Factors; Partial Nephrectomy; Radical nephrectomy; Metastatic renal cell carcinomaRisk FactorsRenal cell carcinomaRetrospective StudieChildAged 80 and overeducation.field_of_studyRadical nephrectomyPrognostic FactorKidney NeoplasmMiddle AgedKidney NeoplasmsNephrectomyRenal cell carcinomaSurvival RateItalyPreoperative nomogramPredictive value of testsPreoperative PeriodFemalePartialHumanAdultmedicine.medical_specialtyKarakiewicz Nomogram; Renal cell carcinoma; cancer specific survivalAdolescentUrologyPopulationMetastatic renal cell carcinomacancer specific survivalUrologyYoung AdultPredictive Value of TestsmedicineHumanseducationSurvival rateCarcinoma Renal CellRetrospective StudiesAgedPrognostic Factorsbusiness.industryRisk FactorRetrospective cohort studyNomogramMetastatic renal cell carcinoma; Nephrectomy; Preoperative nomogram; Prognostic Factors; Renal cell carcinomamedicine.diseaseNomogramsbusinessKidney cancer
researchProduct

Prognostic factors in a large multi-institutional series of papillary renal cell carcinoma.

2011

OBJECTIVES To investigate cancer-related outcomes and prognostic factors of papillary renal cell carcinoma (pRCC) in a large multicentre data set. Oncological outcome and prognostic factors of pRCC have been limitedly evaluated in comparison with the most common RCC subtype, clear cell RCC. PATIENTS AND METHODS From a multicentre retrospective database, including 5463 patients who were surgically treated for RCC at 16 Italian academic centres between 1995 and 2007, 577 patients with pRCC were identified. Univariable and multivariable Cox regression models were performed to identify prognostic factors predictive of recurrence-free survival (RFS) and cancer-specific survival (CSS) after surge…

Malerenal cell carcinomaTime FactorsPapillary renal cell carcinoma; Prognostic factorsPrognosiFEATURESkidney cancer; papillaryrenal cell carcinoma; papillary adenocarcinoma; prognostic factorspapillary renal cell carcinomaNephrectomyCLASSIFICATIONFollow-Up Studiecancer-specific survivalpapillaryRisk FactorsRetrospective StudieCause of DeathPrevalenceHumansrecurrence-free survivalprognostic factorCarcinoma Renal CellTYPE-1Proportional Hazards ModelsRetrospective StudiesNeoplasm StagingAcademic Medical Centerspapillary adenocarcinomaRisk Factorkidney cancerKidney Neoplasmprognostic factorsMiddle AgedPrognosisTUMORSKidney NeoplasmsHISTOLOGIC SUBTYPESPrognostic factors in a large multi-institutional series of papillary renal cell carcinoma.Survival RateAcademic Medical CenterItalySURVIVALProportional Hazards ModelFemaleprognostic factors; papillary renal cell carcinoma; recurrence-free survival; cancer-specific survivalFollow-Up StudiesHuman
researchProduct

Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 years of experience.

2006

We report the long-term results of our consecutive series of 504 patients who underwent NSS for cancer suspicious, solid renal tumors in the presence of a normal opposite kidney at our institution since 1979.A total of 715 patients underwent NSS since 1969, including 504 for an elective indication, that is with a normal opposite kidney. Of these patients 381 (75.6%) had RCC, 123 (24.4%) had cancer suspicious benign lesions, including 53 (10.5%) with oncocytoma, 33 (6.5%) with angiomyo(lipo)ma, 23 (4.6%) with a complicated cyst and 13 (2.8%) with other benign lesions. Of the 381 patients with RCC 283 (74.3%) had clear cell, 68 (17.8%) had papillary and 30 (7.9%) had chromophobic RCC. Mean tu…

NephrologyAdultMalemedicine.medical_specialtyTime FactorsUrologyUrologyNephrectomyRenal cell carcinomaInternal medicinemedicineCarcinomaHumansCystOncocytomaCarcinoma Renal CellAgedAged 80 and overbusiness.industryCancerNephronsMiddle Agedmedicine.diseaseKidney NeoplasmsSurgeryFemalebusinessKidney cancerKidney diseaseFollow-Up StudiesThe Journal of urology
researchProduct

Huge isolated port-site recurrence after laparoscopic partial nephrectomy: a case report.

2009

A 66-yr-old man with pain and swelling in the right flank was referred to our clinic for diagnosis. In 2005, the patient underwent a laparoscopic partial nephrectomy for renal cancer of the lower pole of the right kidney. A computed tomography scan revealed a 20-cm tumor in the right abdominal wall, resulting in a suspected diagnosis of port-site metastasis from the first laparoscopic operation. The patient underwent open surgery, which confirmed the diagnosis. After the operation, the patient recovered rapidly.

NephrologyMalemedicine.medical_specialtyUrologymedicine.medical_treatmentNephrectomySettore MED/24 - UrologiaMetastasisLaparoscopynephrectomy recurrenceAbdominal wallNeoplasm SeedingInternal medicinePort-site metastasismedicineHumansLaparoscopyKidney cancer; Laparoscopy; Port-site metastasisCarcinoma Renal CellAgedmedicine.diagnostic_testbusiness.industryAbdominal WallKidney cancermedicine.diseaseNephrectomyKidney NeoplasmsSurgeryEndoscopymedicine.anatomical_structureLaparoscopybusinessKidney cancerKidney diseaseEuropean urology
researchProduct

Renal tumour surgery in elderly patients.

2008

OBJECTIVE To analyse morbidity, renal function and oncological outcome in patients aged ≥80 years who had surgery for renal tumours, as in the elderly such surgery is controversial in relation to life-expectancy and other causes of death. PATIENTS AND METHODS Between 1990 and 2006, in our institution 1625 patients had surgery to treat solid renal tumours suspected to be renal cell carcinoma (RCC); 62 (4%) were aged ≥80 years (mean 82.5), and 73% of these elderly patients had radical nephrectomy (RN) and 27% nephron-sparing surgery (NSS). Results The median (range) follow-up was 3.1 (0.2–14.1) years (89% of the patients). There was no perioperative mortality. There were only minor complicati…

NephrologyMalemedicine.medical_specialtyUrologymedicine.medical_treatmentRenal functionurologic and male genital diseasesNephrectomyDisease-Free SurvivalPostoperative ComplicationsRenal cell carcinomaInternal medicineMedicineHumansCarcinoma Renal CellSurvival analysisNeoplasm StagingRetrospective StudiesAged 80 and overbusiness.industryAge FactorsPerioperativemedicine.diseasePrognosisSurvival AnalysisNephrectomyKidney NeoplasmsSurgeryTreatment OutcomeFemalebusinessKidney cancerKidney diseaseFollow-Up StudiesBJU international
researchProduct

Nephron-sparing surgery for renal cell carcinoma: detailed analysis of complications over a 15-year period.

2005

To assess the incidence of complications of conservative renal surgery for renal cell carcinoma in both elective and imperative indications, and its evolution over a 15 year period.From 1988 to 2003, 127 patients underwent partial nephrectomy or tumorectomy for renal cell carcinoma in our department. INDICATIONs were imperative in 42% (n = 53) and elective in 58% (n=74) of cases. Morbidity was retrospectively assessed according to four parameters: 1- Period of surgery: A, from 1988 to 1999 and B, from 2000 to 2003. 2- INDICATION: elective vs. imperative. 3- experience of surgeon: senior vs. junior. 4- Nature of complications: minor or major. Comparative analysis was conducted using Chi-squa…

NephrologyReoperationmedicine.medical_specialtyUrinary FistulaUrologymedicine.medical_treatmentHemorrhageNephrectomyPostoperative ComplicationsRenal cell carcinomaInternal medicineCarcinomamedicineHumansCarcinoma Renal Cellbusiness.industryIncidence (epidemiology)Acute Kidney Injurymedicine.diseaseNephrectomyKidney NeoplasmsSurgeryTreatment OutcomeComplicationbusinessKidney cancerKidney diseaseFollow-Up StudiesEuropean urology
researchProduct

Open Radical Nephrectomy: 35 Years of Experience at the “Luciano Giuliani” Urological Department of the University of Genoa

2006

Objective: Radical nephrectomy remains the gold standard for surgically resectable kidney neoplasms > 4 cm and, in selected cases, also in presence of metastatic disease. We reviewed the records of the patients having surgery at the University of Genoa in the last 35 yr. Methods: We have retrospectively assessed all the radical nephrectomies performed between 1970 and 2005. Among tumours of the kidney subjected to surgical treatment during this period, we found 1105 cases of histologically proven renal cell carcinoma (RCC), 965 of which had records available for the study. The number of cases per year, symptoms at diagnosis, surgical strategy, staging of the tumour, and survival were rev…

Nephrologycancer incidencemedicine.medical_treatmentkidney carcinomamorbiditysepsisRenal cell carcinomacancer diagnosiscancer mortalitynephrectomypostoperative complicationMyocardial infarctioncancer survivaldisease free survivalcancer diagnosiadrenalectomy; article; cancer diagnosis; cancer incidence; cancer mortality; cancer size; cancer staging; cancer surgery; cancer survival; disease free survival; heart infarction; human; kidney carcinoma; lung embolism; lymphadenectomy; metastasis; morbidity; nephrectomy; partial nephrectomy; postoperative complication; priority journal; sepsis; spleen injury; splenectomy; surgical technique; thrombectomyRadical nephrectomyIncidence (epidemiology)articleadrenalectomyRenal cell carcinomaNephrectomypriority journalthrombectomysepsicancer surgerylung embolismmedicine.medical_specialtypartial nephrectomyUrologyheart infarctionsurgical techniquesplenectomyInternal medicinemedicineCarcinomametastasishumanbusiness.industrycancer stagingmedicine.diseaseSurgeryspleen injurycancer sizelymphadenectomySurgerymetastasibusinessKidney cancerKidney diseaseEuropean Urology Supplements
researchProduct

A Clinical Trial With Chimeric Monoclonal Antibody WX-G250 and Low Dose Interleukin-2 Pulsing Scheme for Advanced Renal Cell Carcinoma

2005

WX-G250 is a chimeric monoclonal antibody that binds to carbonic anhydrase IX(G250/MN), which is present on greater than 95% of RCCs of the clear cell subtype. The suggested working mechanism of WX-G250 is by ADCC. Because the number of activated ADCC effector cells can be increased by a low dose interleukin-2 pulsing schedule, a multicenter study was initiated to investigate whether WX-G250 combined with LD-IL-2 could lead to an improved clinical outcome in patients with progressive RCC.A total of 35 patients with progressive clear cell RCC received weekly infusions of WX-G250 for 11 weeks combined with a daily LD-IL-2 regimen. Patients were monitored longitudinally for ADCC capacity. Radi…

OncologyAdultMalemedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentUrologyMonoclonal antibodyTranslational research [ONCOL 3]Renal cell carcinomaInternal medicineCarcinomaMedicineHumansProspective StudiesCarcinoma Renal CellAgedAntibody-dependent cell-mediated cytotoxicitybiologybusiness.industryAntibodies MonoclonalImmunotherapy gene therapy and transplantation [UMCN 1.4]ImmunotherapyMiddle Agedmedicine.diseaseKidney NeoplasmsImmunologybiology.proteinDisease ProgressionInterleukin-2Drug Therapy CombinationFemaleAntibodybusinessKidney cancerProgressive diseaseThe Journal of Urology
researchProduct

SEOM clinical guideline for treatment of kidney cancer (2017)

2017

Abstract The goal of this article is to provide recommendations about the management of kidney cancer. Based on pathologic and molecular features, several kidney cancer variants were described. Nephron-sparing techniques are the gold standard of localized disease. After a randomized trial, sunitinib could be considered in adjuvant treatment in high-risk patients. Patients with advanced disease constitute a heterogeneous population. Prognostic classification should be considered. Both sunitinib and pazopanib are the standard options for first-line systemic therapy in advanced renal cell carcinoma. Based on the results of two randomized trials, both nivolumab and cabozantinib should be consid…

OncologyCancer Researchmedicine.medical_specialtyCabozantinibhumanosRonyóClinical Guides in Oncologyurologic and male genital diseasesKidneylaw.inventionPazopanib03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRandomized controlled trialRenal cell carcinomalawInternal medicinemedicineHumans030212 general & internal medicineCàncerCarcinoma Renal CellCancerMolecular pathologyAdjuvant treatment of cancerneoplasias renalesSystemic therapybusiness.industrySunitinibCarcinomaCorrectionKidney cancerGeneral Medicinemedicine.diseaseKidney NeoplasmsOncologychemistry030220 oncology & carcinogenesisLocalized diseaseNivolumabbusinessKidney cancermedicine.drugTractament adjuvant del càncer
researchProduct

Epulis-Like Presentation of Gingival Renal Cancer Metastasis

2017

Mouth metastatic cancers are very rare and they usually represent the evidence of a widespread disease. Common primary tumors are lung carcinoma in men and breast carcinoma in women, followed by kidney cancer. In the oral soft tissues, the gingiva is the most common site, suggesting a possible role of inflammation in the attraction of circulating tumor cells. Oral metastasis has a serious prognosis. In this work, we describe the case of a 58-year-old man affected by renal cancer, who was brought to our attention for the appearance of a gingival swelling. Initially, the lesion was excised through a provisional clinical diagnosis of epulis. Subsequently, anatomopathological analysis showed a …

OncologyPathologymedicine.medical_specialtyEpulisOphtalmologieCase Reportlcsh:RC254-282MetastasisMetastasis03 medical and health sciences0302 clinical medicineCirculating tumor cellClear-cell adenocarcinomaInternal medicineCarcinomamedicineClear-cell adenocarcinomaRiñones -- CáncerCell proliferationbusiness.industryOral cancerCancerMetástasisKidney cancer030206 dentistryCáncerlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseBoca -- CáncerOncology030220 oncology & carcinogenesisbusinessBreast carcinomaKidney cancer
researchProduct